Dietary phosphorus and an inflammatory challenge affect performance and immune function of weanling pigs.
Ninety-six 3-wk-old pigs (6.3+/-0.12 kg initial BW) were allotted to one of eight treatments based on BW and litter origin to determine the effect of dietary phosphorus and an inflammatory challenge on performance and immune function. Four corn-soybean meal-based treatment diets were formulated to contain 0.16, 0.24, 0.32, or 0.40% available P. Monocalcium-dicalcium phosphate was used as the supplemental P source. The Ca:available P ratio was maintained at 2:1. To challenge the pigs, half of the pigs in each dietary treatment were injected i.m. with E. coli lipopolysaccharide (200 microg/kg of BW) on d 7 and 14. This resulted in a 2 x 4 factorial arrangement of treatments. Average daily gain for the 35-d study was increased linearly (P < 0.01) by increasing supplemental P. Average daily gain and ADFI were decreased (P < 0.05) by lipopolysaccharide injection. Serum P concentrations increased linearly (P < 0.01) with increasing supplemental P. Antibody titers to the injection of sheep red blood cells and ovalbumin on d 21 decreased linearly (P < 0.10) by increasing supplemental P. In vitro blastogenic response of lymphocytes to phytohemagglutinin (PHA) on d 25 was increased linearly (P < 0.05) by increasing supplemental P. Blastogenic response of lymphocytes to pokeweed mitogen on d 25 was not affected. On d 31, skinfold thickness 6 h following an intradermal injection of PHA was increased quadratically (P < 0.07) by increasing supplemental P. There were no P x lipopolysaccharide interactions for any immune response measure. In conclusion, increasing supplemental P increased ADG and enhanced cell-mediated immune response but decreased humoral immune response.
Kegley
E B
EB
Department of Animal Science and Interdepartmental Nutrition Program, North Carolina State University, Raleigh 27695-7621, USA.
Spears
J W
JW
Auman
S K
SK
D000818:Animals; D000906:Antibodies / Q000097:blood; D004797:Enzyme-Linked Immunosorbent Assay / Q000662:veterinary; D005260:Female; D007109:Immunity / Q000187:drug effects*; D016014:Linear Models; D008070:Lipopolysaccharides / Q000276:immunology / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects / Q000276:immunology; D008214:Lymphocytes / Q000187:drug effects; D008297:Male; D016226:Phosphorus, Dietary / Q000097:blood / Q000276:immunology* / Q000494:pharmacology; D010835:Phytohemagglutinins / Q000276:immunology / Q000494:pharmacology; D011043:Pokeweed Mitogens / Q000276:immunology / Q000494:pharmacology; D012885:Skinfold Thickness; D013552:Swine / Q000276:immunology* / Q000378:metabolism / Q000502:physiology
D000906:Antibodies; D008070:Lipopolysaccharides; D016226:Phosphorus, Dietary; D010835:Phytohemagglutinins; D011043:Pokeweed Mitogens